Abstract | BACKGROUND: MATERIAL AND METHODS: A total of 35 adult female Wistar rats, mean weight 250 g, were randomly allocated to 3 experimental groups: group1, sham-operated (n=10); group 2, partial BOO group (n=14) and group 3, partial BOO group treated with doxazosin (n=11). Partial BOO in rats was surgically induced. Results were assessed by eNOS immunohistochemistry. RESULTS: eNOS staining in kidneys in group 1 (16.45 ± 1.63) was significantly higher than in group 2 (5.09 ± 0.61) (p<0.05). After 15 days of doxazosin treatment in addition to partial BOO (group 3), eNOS staining in the kidney (11.80 ± 1.63) was significantly higher than in group 2 (5.09 ± 0.61) (p<0.05). In samples taken after 15 days of doxazosin treatment in addition to partial BOO, eNOS staining in kidneys (11.80 ± 1.63) was lower than in the sham-operated group (16.45 ± 1.63), but the difference was not significant (p>0.05). CONCLUSION: These findings may provide insight into the beneficial and restorative effects of α(1)-adrenoceptor antagonists on eNOS expression in the kidney, when used to treat symptoms of benign prostate hyperplasia and hypertension.
|
Authors | Omer Kutlu, Mehmet Yalcinkaya, Selcuk Kutlu, Gulsum O Elpek, Ismail T Köksal, Erdal Kukul |
Journal | Journal of nephrology
(J Nephrol)
2012 Sep-Oct
Vol. 25
Issue 5
Pg. 750-4
ISSN: 1724-6059 [Electronic] Italy |
PMID | 22135033
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic alpha-1 Receptor Antagonists
- Nitric Oxide Synthase Type III
- Nos3 protein, rat
- Doxazosin
|
Topics |
- Adrenergic alpha-1 Receptor Antagonists
(pharmacology)
- Animals
- Disease Models, Animal
- Doxazosin
(pharmacology)
- Female
- Immunohistochemistry
- Kidney
(drug effects, enzymology)
- Nitric Oxide Synthase Type III
(metabolism)
- Rats
- Rats, Wistar
- Time Factors
- Up-Regulation
- Urinary Bladder Neck Obstruction
(drug therapy, enzymology)
|